ElevateBio Executive and Leadership Team

Christopher Murphy, the Chief Executive Officer at ElevateBio, directs the overarching corporate strategy and long-term vision for the organization. By fostering partnerships with leading scientists and inventors, the Chief Executive Officer expands the reach of the company's cell and gene therapy portfolio. This leadership role involves constant engagement with the Board to ensure alignment with market demands and scientific breakthroughs. Christopher Murphy maintains a focus on scaling the business model to support emerging biotech ventures across North America. Through rigorous oversight of capital allocation and strategic growth initiatives, the Chief Executive Officer drives the company toward becoming a dominant force in the genetic medicine sector. Murphy ensures that every portfolio company receives the necessary resources to advance clinical development programs efficiently. Ultimately, the Chief Executive Officer secures the competitive positioning of the entire enterprise within the global biotechnology landscape.

Bhakti Bhargava, the Chief Financial Officer at ElevateBio, manages the fiscal health and investment strategies required to sustain the company's portfolio of therapy developers. Overseeing financial planning, analysis, and reporting, the Chief Financial Officer ensures that capital resources support high-impact research and development projects. This role involves coordinating with external investors and internal stakeholders to maintain robust liquidity for ongoing operations. Bhakti Bhargava directs the financial modeling for new partnerships, evaluating the economic viability of potential cell and gene therapy ventures. By optimizing the cost structure across the organization, the Chief Financial Officer improves operational efficiency and supports sustainable growth. Bhargava monitors market trends to mitigate financial risks while identifying opportunities for expansion. Through precise fiscal management, the Chief Financial Officer provides the stability necessary for the company to advance complex medical technologies from the laboratory to clinical application.

Kareem Reda, the Chief Operating Officer at ElevateBio, governs the internal processes and organizational infrastructure that enable the company's portfolio firms to thrive. By streamlining cross-functional workflows, the Chief Operating Officer ensures that administrative and operational systems align with the specific needs of cell and gene therapy development. This leadership role involves managing the integration of new ventures into the broader corporate ecosystem. Kareem Reda directs the implementation of scalable business practices that allow for rapid expansion across regional markets. Through the coordination of internal resources, the Chief Operating Officer supports the seamless execution of research and manufacturing goals. Reda monitors performance metrics to identify bottlenecks and implements solutions that enhance productivity. By maintaining a focus on operational excellence, the Chief Operating Officer provides the foundational support required for the company to deliver innovative medical solutions to patients worldwide.

Michael Paglia, the Chief Technology Officer, Elevatebio Basecamp at ElevateBio, architects the advanced technical infrastructure and manufacturing capabilities essential for genetic medicine production. Overseeing the development of proprietary platforms, the Chief Technology Officer, Elevatebio Basecamp ensures that the company maintains a cutting-edge advantage in cell and gene therapy manufacturing. This role involves managing complex laboratory environments and technical teams to accelerate the transition of therapies from concept to clinical trial readiness. Michael Paglia directs the integration of innovative technologies that improve process efficiency and product quality. By collaborating with scientific partners, the Chief Technology Officer, Elevatebio Basecamp optimizes the technical pathways required for successful therapeutic development. Paglia monitors emerging industry standards to ensure that all technological assets remain at the forefront of the biotech sector. Through technical leadership, the Chief Technology Officer, Elevatebio Basecamp drives the innovation necessary to solve critical manufacturing challenges.